Abstract
Infections caused by multi-drug resistant (MDR) pathogenic bacteria are a global health threat. Phage therapy, which uses phage to kill bacterial pathogens, is increasingly used to treat patients infected by MDR bacteria. However, the therapeutic outcome of phage therapy may be limited by the emergence of phage resistance during treatment and/or by physical constraints that impede phage-bacteria interactionsin vivo. In this work, we evaluate the role of lung spatial structure on the efficacy of phage therapy forPseudomonas aeruginosainfection. To do so, we developed a spatially structured metapopulation network model based on the geometry of the bronchial tree, and included the emergence of phage-resistant bacterial mutants and host innate immune responses. We model the ecological interactions between bacteria, phage, and the host innate immune system at the airway (node) level. The model predicts the synergistic elimination of aP. aeruginosainfection due to the combined effects of phage and neutrophils given sufficiently active immune states and suitable phage life history traits. Moreover, the metapopulation model simulations predict that local MDR pathogens are cleared faster at distal nodes of the bronchial tree. Notably, image analysis of lung tissue time series from wild-type and lymphocyte-depleted mice (n=13) revealed a concordant, statistically significant pattern: infection intensity cleared in the bottom before the top of the lungs. Overall, the combined use of simulations and image analysis ofin vivoexperiments further supports the use of phage therapy for treating acute lung infections caused byP. aeruginosawhile highlighting potential limits to therapy given a spatially structured environment, such as impaired innate immune responses and low phage efficacy.
Publisher
Cold Spring Harbor Laboratory
Reference55 articles.
1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis;The Lancet,2022
2. World Health Organization et al., “2021 antibacterial agents in clinical and preclinical development: an overview and analysis,” World Health Organization, 2022.
3. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections
4. In Vitro and In Vivo Bacteriolytic Activities of
Escherichia coli
Phages: Implications for Phage Therapy
5. Characterization and anti-biofilm activity of bacte-riophages against urinary tract enterococcus faecalis isolates;Scientific Reports,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献